The present study examines the prevalence of death thoughts and suicidality in HIV infection. Subjects (n ¼ 246) were examined for psychiatric morbidity and suicidality. Compared to high risk HIV seronegatives, HIV seropositives (HIVþ) had significantly increased frequency and severity of both suicidal ideation and death thoughts. Two-thirds of seropositives had suicidal ideation at some point; half of the seropositives reported suicide plans and one quarter suicide attempts; and third of seropositives reported current suicidal ideation. Suicidal ideation did not increase with advancing disease. The high prevalence of suicidal ideation suggests inclusion of its assessment in HIV treatment regardless of stage.
A number of clinical investigators have found that psychological distress is significantly increased in HIVþ subjects (Atkinson et al., 1988; Baer, 1989; Jacobsen, Perry, & Hirsch, 1990; Kovner et al., 1989; King, 1989; Massie, Tross, Price, Holland, & Redd, 1987; Miller & Riccio, 1990; Naber et al., 1990; O'Dowd, 1988; Perry, Jacobsberg, Fishman, Frances et al., 1990; Williams, Rabkin, Remien, Gorman, & Ehrhardt, 1991) . Prior to the advent of potent antiretroviral treatment, the most prevalent manifestations of this were increased anxiety and depressive symptoms. Possible etiologies include: 1) multiple psychological stressors, including loss of physical health and well being, social isolation due to death of friends or fear of contagion, societal reaction to the disease, and loss of income due to physical illness; 2) the possibility that persons who are depressed may behave in ways that put them at risk for acquiring HIV; and 3) central nervous system (CNS) effects of HIV (Kalichman et al., 2000) .
Among hospitalized patients with AIDS, depression has been shown to be the strongest predictor (23% of the variance) of quality of life (Kemppainen, 2001) . The most serious complication of depression and anxiety is suicide. Studies have found that between 1.9 and 4.6% of persons in the United States admit having attempted suicide (Kessler et al., 1999; Kuo et al., 2001) . HIV infection has been found to be related to suicidal ideation and attempts (Komiti et al., 2001) . Further more, a number of other risk factors common among persons with HIV (lack of employment, financial difficulties, substance use, physical and sexual abuse, and social isolation) have been shown to predict suicidality (Brady et al., 2002; Cooperman & Simoni, 2003; Roy, 2003) . Therefore, HIV seropositive (HIVþ) subjects may be at higher risk of suicide than the general population; however, findings in the literature are unclear concerning the prevalence of suicide in the HIVþ population. Numerous studies indicate this population is at an increased risk of suicidal thoughts and behavior (Cote, Biggar, & Dannenberg, 1992; Gala et al., 1992; Joseph, Caumartin et al., 1990; Marzuk et al., 1988; McKegney & O'Dowd, 1992; Rajs & Fugelstad, 1992; Ritchie, Radke, & Ross, 1992; Schneider, Taylor, Kemeny, & Hammen, 1991) . However, there are also studies that suggest that HIVþ individuals are not at higher risk for suicidal ideation than are their seronegative counterparts Schneider et al., 1991) .
Stage of disease may be a factor for increasing risk of suicide and thoughts of death. Although thoughts of death and suicidal ideation may occur independent of one another, it might be expected that both would increase with advancing disease stage, as many of the potential etiological factors are exacerbated by declining health. Studies have indicated that people are more likely to have suicidal thoughts when they are depressed and have physical symptoms concommitantly. Bellini and Bruschi (1996) found increased suicidal ideation in the period of testing in both HIV seropositive and seronegative persons. They also found that HIV seropositive persons are particularly susceptible to suicidal ideation during the first three months following diagnosis.
In the era prior to the advent of highly active antiretroviral therapy (HAART), a diagnosis of HIVþ meant the very real possibility of degeneration to a vegetative state, and ultimately death. It is common for individuals afflicted with serious and=or fatal diseases to experience increased thoughts of death, unrelated to suicidal ideation. Thoughts of death (e.g., ''life is not worth living''), in addition to suicidality, have been assessed in studies looking at normal elderly populations (Scocco et al., 2001; Scocco & Deleo, 2002) . Because increased thoughts of death and dying are natural for individuals coming to terms with a terminal illness, it is important to view these separately from suicidal ideation.
Thoughts of death and death anxiety may be viewed as states of distress accompanied by one's encounter with death or its prospect (Neimeyer et al., 2005) . Death related anxiety may involve apprehension of the dying process and pain, doubts=fear of the afterlife, as well as the effects on loved ones. Research findings suggest that older subjects tend to endorse less death thoughts than middle-aged or younger subjects (Neimeyer & Fortner, 1996) . Furthermore, within older patients, heightened death anxiety has been found to be correlated with physical health problems, psychological distress, weaker religious beliefs, and low life satisfaction (Fortner & Neimeyer, 1999) . Feifel and Branscomb's (1973) study concluded that although the terminally ill think about death more, they do not reveal any deeper anxiety than the healthy person. Although many studies have supported this conclusion, it seems natural to assume at least some sort of covert anxiety exists. Results from a number of studies on homosexual HIVþ men suggest that they are more afraid of premature death than a healthy individual, and that greater death anxiety was associated with less family support (Catania, Turner, Choi, & Coates, 1992) .
Utilizing a well-characterized population, the purpose of the present study was: 1) to assess the prevalence of thoughts about death and suicidal ideation, both current and lifetime, in a heterogeneous sample of well studied HIVþ subjects in the pre-HAART era; 2) to evaluate the effects of elevated levels of thoughts about death and suicidal ideation for individuals at advanced stages of disease progression; 3) and to compare the results to those in high-risk HIV seronegative controls (HIVÀ). We hypothesized that HIVþ subjects compared to HIVÀ subjects would have increased thoughts of death and suicidal ideation. We also hypothesized that elevated levels of thoughts about death and suicidal ideation would be present for individuals at advanced stages of disease progression.
Methods

Subjects
Two hundred and forty-six subjects, voluntarily enrolled in longitudinal studies of the effects of HIV on the nervous system (UNC AIDS Neurological Center), completed a protocol that included psychological, neurological, neuropsychological, clinical neurophysiological (EEG and evoked potentials), magnetic resonance imaging=spectroscopy, and laboratory evaluations. Subjects were recruited from infectious disease clinics, hemophilia clinics, statewide support groups and word of mouth; subjects represented a broad range of both sociodemographic and risk factors. No subject was entered into the study specifically due to identified neurological or psychological difficulties. Of note, these subjects were assessed during the pre-HAART era. Fifty-five were high risk HIV seronegative (HIVÀ) comparison subjects and 191 were HIV seropositive (HIVþ ). Of the HIVþ , 78 (41%) were asymptomatic (ASX, CDC Categories A1-A2), 36 (19%) were symptomatic without AIDS (SX, CDC Categories B1-B2), and 77 (40%) had AIDS (CDC Categories A3, B3, C1-C3). Demographic variables of the sample are shown Table 1 . The risk factors in the HIVþ sample included homosexual contact in 64%, exposure to blood products and sexual contact in 7%, heterosexual contact only in 11%, and intravenous substance abuse and sexual contact in 18% subjects. The HIVÀ subjects had homosexual contact in 42%, exposure to blood products and sexual contact in 35%, heterosexual contact only in 20%, and intravenous substance abuse and sexual contact in 4% subjects as their primary risk factor.
Instruments
Subjects were administered the following: a semi-structured interview; the National Institutes of Mental Health (NIMH) Diagnostic Interview Schedule (DIS; Robins, Helzer, Croughan, Williams, & Spitzer, 1985) ; the Minnesota Multiphasic Personality Inventory 2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) ; and the Brief Symptom Inventory (BSI; Derogatis & Spencer, 1982) . The MMPI-2 is a well standardized self-report instrument consisting of 13 basic scales: ten clinical scales (Hypochondriasis, Depression, Hysteria, Psychopathic Deviate, Masculinity-Femininity, Paranoia, Psychasthenia, Schizophrenia, Hypomania, Social Introversion) and three validity scales (Lie, Infrequency and Correction). Four items from the MMPI-2 were specific to the aims of the study: item 303 ''Most of the time I wish I were dead;'' item 506 ''I have recently considered killing myself;'' item 520 ''Lately I have thought a lot about killing myself'' and item 524 ''No one knows it but I have tried to kill myself.'' These items were coded dichotomously as true=false. The BSI is a self-report instrument measuring nine factors: Somatization, Obsessiveness, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychoticism. Three global measures of psychological functioning are derived from the BSI: Positive Symptom Total, Positive Symptom Distress Index and the Global (64) 155 (81) Thoughts of Death and Suicidal Ideation in HIVSeverity Index. Two items from the BSI were specific to the aims of the study: item 9 ''Thoughts of ending your life'' and item 39 ''Thoughts of death or dying;'' each is coded on a 5 point scale of never, a little bit, moderately, quite a bit and extremely. The three items from the semi-structured interview were ''Have you thought about harming yourself,'' ''Did you have a plan about how to do this,'' and ''Did you attempt to follow through with this.'' These items were dichotomously coded as yes=no. The structured interview utilized was the National Institutes of Mental Health (NIMH) Diagnostic Interview Schedule (DIS; Robins, Helzer, Croughan, Williams, & Spitzer, 1985) . The DIS has been widely used in the NIMH Epidemiological Catchment Area Program (Reiger et al., 1984) , and studies have demonstrated adequate reliability and validity (Burke, 1986) . The four items from the DIS were ''Has there ever been a period of two weeks or more when you thought a lot about death-either your own, someone else's or death in general,'' ''Have you felt like you wanted to die,'' ''Have you felt so low you thought of committing suicide,'' and ''Have you ever attempted suicide.'' These items were dichotomously coded as yes=no.
Procedure
Subjects' recruitment and interviews occurred between September 1988 and June 1998. Upon entry into the study, a clinical psychologist or a predoctoral clinical psychology student administered the DIS. The interview consisted of unstructured and structured segments requiring durations of one to two and a half hours. Subjects then completed the self-report instruments. Subjects were admitted as inpatients to the NIH General Clinical Research Center at the University of North Carolina at Chapel Hill, and all interviews were conducted in the privacy of the patient's room.
Data Analyses
Current items were derived from the BSI (which measures symptoms within the past week) and the MMPI-2 items with ''recent'' item content. The remaining items were labeled lifetime and refer to meeting criteria at some point in life. To compare the rates found in the HIVþ and HIVÀ subjects, Chi square statistics were . Power and effect sizes were assessed with alpha set at .05, beta at .20, power (1-beta) at .80. A large effect size (.5) was chosen so that differences would be clinically meaningful. The available sample sizes exceeded those specified by the power analyses: with df ¼ 1 (2 Â 2 tables), n ¼ 31 was required; for df ¼ 2 (3 Â 2), n ¼ 39 was required. Measures of association were also computed using Spearman or Pearson product moment correlations where appropriate. To measure severity of suicidal ideation, analyses of variance between groups (HIVÀ=HIVþ; ASX=SX=AIDS) with dependent variables of raw BSI items were calculated. Analysis of variance between groups (suicidal=nonsuicidal) with the dependent variable of the MMPI-2 Depression score was calculated. To control for error associated with multiple statistical comparisons, the False Discovery Rate (FDR) procedure was used to adjust significance levels across the study (Benjamini & Hochberg, 1995; Williams, Jones, & Tukey, 1994) . The FDR is a sequential step up procedure utilized to adjust alpha for excessive power and reduce Type I errors when performing multiple comparisons. All analyses were completed with SAS.
Results
The frequency of positive responses to the thoughts about death and suicide variables by HIV serostatus and disease stage is shown in Table 2 . HIVþ subjects reported significantly increased current and lifetime thoughts about death when compared to HIVÀ subjects. Current and lifetime suicidal ideation was also significantly increased in the HIVþ subjects when compared to the HIVÀ subjects. No significant differences were found in suicide attempts, although a trend for increased attempts was noted for the HIVþ subjects. Across the stages of HIV disease (ASX, SX, AIDS), no significant differences were found for the current or lifetime suicidal ideation items. A trend for increased current thoughts about death was found in the SX subjects. For current suicidal ideation (BSI, ''thoughts of ending your life''), significant differences in severity were found between HIVÀ and HIVþ subjects (F(1, 243) 
Discussion
The present study supports the initial hypothesis that both suicidal ideation and thoughts about death are significantly increased in HIVþ subjects when compared to high risk seronegative comparison subjects. As might be expected in a life-threatening illness, thoughts of death were even more frequent than suicidal ideation in the HIVþ subjects. Sixty-three percent reported current thoughts about death compared to 20% in the BSI normative sample (BSI, Derogatis & Spencer, 1982) . Eighty-nine percent reported lifetime thoughts about death. In addition, 68% of the group reported lifetime and 35% reported current suicidal ideation. This frequency is much higher than that found in the BSI normative sample (Derogatis & Spencer, 1982) , where 3% reported current suicidal ideation. Attempted suicide in the group was relatively frequent (25% in lifetime). Successful suicide, however, was uncommon. Only one subject was known to have completed suicide, and another death was considered a possible suicide.
Although there is a great deal of literature on HIV and suicidal ideation, reporting of death thoughts (e.g., BSI Item 39 ''Thoughts of death or dying'') and death wishes (e.g., MMPI-2 Item 303 ''Most of the time I wish I were dead'') are frequently underreported. The rationale for this remains unclear. Skoog et al. (1996) found a prevalence of 6.7% of male participants proffering ''death thoughts,'' compared to 7.7% reporting ''death wishes.'' As Scocco and De Leo (2002) point out, this may be because thoughts of death are presented separately from beliefs related to the value of life. So, while an individual may entertain thoughts of death, that same individual may value life and reject suicidal thoughts. Scocco and De Leo contend that while elderly persons deny suicidal ideation, they may have increased death thoughts due to unhappiness about the aging-related restrictions placed upon their ability to live their lives in a manner that reflects their values and expectations. This may help explain our findings that: 1) death thoughts are significantly greater in HIVþ subjects when compared to high risk seronegative comparison subjects; and 2) that death thoughts were even more frequent than suicidal ideation in the HIVþ subjects. Like Scocco and De Leo's elderly sample, HIVþ persons may have increased death thoughts as they face restrictions to their independence and quality of life.
Results did not support the second hypothesis that both suicidal ideation and thoughts of death and dying would increase with disease progression. Disease stage did not significantly influence suicidal ideation; ASX, SX and AIDS subjects reported similar current and lifetime frequencies. There was a trend for increased current thoughts about death or dying in the SX subjects, but no lifetime differences were found. This may be due to the role of an adaptive process that decreases death thought accessibility after acknowledgement of disease status. Although some studies have concluded that disease factors are related to suicidal ideation, others suggest that over time, some HIV seropositive persons develop increased adaptive coping strategies that help them deal with thoughts of death. O'Dowd et al. (1993) found that persons with AIDS tend to have less suicidal ideation than persons with asymptomatic or symptomatic HIV. On initial confrontation with a diagnosis of HIV persons may experience increased death thoughts; however, over time they may also develop adaptive strategies to the new reality, which limits a corresponding increase in thoughts of death.
In HIVþ individuals, major peaks in psychological distress appear to occur post testing positive, at the onset of the first symptoms of illness (SX) and at the first AIDS defining illness (O'Dowd, 1988; . Increases in death thoughts may 464 K. Robertson et al. occur in parallel with peaks in psychological distress. On historical clinical interview, subjects in the present sample very often reported having thoughts of death immediately after testing HIVþ. This comes at a time when the individual is severely threatened and in psychological shock, which may overwhelm available coping resources. These early thoughts of death may reflect anxieties related to thoughts of a painful death, afterlife concerns, or a realization that one's hopes and dreams will not be fulfilled. It was also common for subjects in the asymptomatic phase of the disease to relate that they had plans to commit suicide when severe medical illness began to manifest itself. This could be regarded as plans for bringing an end to severe pain, lost functioning, or other severe decrement in quality of life. However, in individuals with AIDSdefining illnesses in this sample, no significant increases in suicidal ideation or attempts were found. Like the persons with increased adaptive coping in the study performed by O'Dowd et al. (1993) , individuals at this stage have generally had more time to adjust to the illness, marshaled effective coping resources, and have more acceptance of the death process. In some, the ''wait'' is over, providing relief from the catastrophic fears of the unknown. Others are preoccupied with the daily challenges of fighting the disease. It may also be that, as death comes closer, life becomes more precious.
It is important to note that these data were collected during the pre-HAART era. Given the advent of potent antiretroviral therapy, there is a definite shift in what it means to be HIVþ . Prior to potent therapy, a diagnosis of HIVþ meant the very real possibility of severe loss of independence and ultimately death. It may be argued that advances in treatment may have affected people's orientation to the disease and the ways in which this affected their thoughts of death and suicidal ideation. Future research assessing the prevalence of thoughts about death and suicidal ideation in HIVþ persons should compare results from both the pre-HAART and HAART eras.
It has been widely suggested that HAART has resulted in improved physical health, increased perceptions that HIV=AIDS is less threatening, increased perceptions of control over health, decreased fear of HIV=AIDS, and decreased need for avoidant coping strategies. Future studies should examine the ways in which health appraisals, life stressors, and coping strategies differ among persons living with HIV=AIDS in the HAART era compared to persons in the pre-HAART era. Further, future research should assess thoughts regarding death in greater detail so as to be able to sort out the different implications of what it means for a person infected with HIV to be concerned about death. As Neimeyer, Stewart, and Anderson (2005) have illustrated, thoughts of death are complex ideational material that may encompass a host of multifarious fears and anxieties (e.g., dying painfully, afterlife concerns, unfulfilled life purposes, and impact upon loved ones), as well as positive forms of life review in the face of anticipated mortality, and making practical preparations for one's estate or medical care in light of the HIV diagnoses. Hence, future research should find ways to elicit a significant sample of death-relevant constructs (e.g., painful vs. painless, familiar vs. unfamiliar, and meaningful vs. meaningless) from the respondent to reveal the HIV infected person's views on death (Neimeyer, 1994a; Neimeyer, 1994b) .
In summary, HIV infection is a protracted and stigmatizing illness which can lead to the loss of both physical and cognitive functioning. Thoughts of death in HIV infection have obvious important implications for clinicians and their patients, and for general health care policy. Although there is controversy in the literature addressing psychological status at HIV testing and over the subsequent disease course, it is clear that there is great potential for psychological distress and the possible need for psychological intervention. Given this and the high prevalence of death thoughts shown in our sample as well as in studies cited above, the possibility of suicide should not be overlooked in the treatment of HIVþ individuals, regardless of disease stage.
